DEFA14A: TAO Synergies Inc. Supplements Proxy Statement, Details New Stock Option Awards and Voting Updates

TAO Synergies Inc. issued a supplement to its definitive proxy statement, detailing new stock option awards for board and management and clarifying voting procedures for its upcoming August 6, 2025 Special Meeting.

Summary

• Supplement No. 1, dated July 18, 2025, updates the definitive proxy statement filed on July 7, 2025, for the Special Meeting of Stockholders to be held on August 6, 2025.
• The Board approved an aggregate of 74,000 non-qualified stock options for members of the Board and management, contingent on stockholder approval of an increase in shares available for grant under the Company's 2020 Equity Incentive Plan.
• The exercise price for these options is $10.38, which was the closing price of the Company's common stock on The Nasdaq Capital Market on July 14, 2025.
• These options have a ten-year term and vest 100% on the one-year anniversary of the grant date.
• Proposal 2 of the Proxy Statement relates to amending the 2020 Equity Incentive Plan to increase the number of shares available for awards by 2,000,000 shares and to change the plan's name to TAO Synergies Inc. 2020 Equity Incentive Plan.
• The Company clarified that all proposals (Issuance, Plan Amendment, and Adjournment) are non-routine, meaning brokerage firms cannot vote unvoted shares held in street name, and broker non-votes will have no effect on the results.
• The number of eligible votes for holders of Series C Preferred Stock on an as-converted basis was corrected from 256,802 to 220,347.

Sentiment

Score: 6

Explanation: The document is primarily procedural, but the proposed stock option awards for management and the board, contingent on shareholder approval, can be viewed as a positive step towards aligning their interests with those of stockholders. The correction of voting shares is a minor administrative issue.

Positives

• The approval of 74,000 non-qualified stock options for board and management, contingent on stockholder approval, aims to align their interests with those of stockholders.
• The stock options have a 10-year term and vest 100% after one year, providing a long-term incentive for key personnel.

Negatives

• The Company discovered and corrected an error in the tabulation of eligible votes for Series C Preferred Stock holders, which was previously overstated by 36,455 votes.

Risks

• The award of stock options and the proposed increase of 2,000,000 shares for the equity incentive plan are subject to stockholder approval, meaning they may not be implemented if shareholders vote against Proposal 2.
• The amounts and recipients of future grants under the Plan are not determinable at this time, introducing uncertainty regarding potential future dilution and compensation allocations.

Future Outlook

The Company anticipates making material additional grants under the 2020 Plan to members of its management team and Board shortly after the Special Meeting, assuming stockholder approval of Proposal 2.

Management Comments

• "To Our Stockholders: You recently received a copy of the proxy statement relating to the Company’s Special Meeting to be held on August 6, 2025."
• "THIS SUPPLEMENT SHOULD BE READ IN CONJUNCTION WITH THE PROXY STATEMENT."

Industry Context

This filing is a standard corporate governance update related to executive and board compensation, a common practice in publicly traded companies to align management incentives with shareholder value. The proposed increase in the equity incentive plan pool is typical for companies seeking to retain and attract talent within competitive markets.

Comparison to Industry Standards

• The compensation structure involving non-qualified stock options with a 10-year term and one-year vesting is a common incentive mechanism used across various industries to align management and board interests with long-term shareholder value.
• The proposed increase of 2,000,000 shares for the equity incentive plan is a significant expansion, but without specific peer company data on their equity compensation pools relative to market capitalization or employee count, a direct comparative assessment of its scale against industry standards is not possible.
• The document does not provide operational or financial performance metrics that would allow for a direct comparison of the company's results against global benchmarks or specific comparable companies/projects.

Corporate Governance

Related Party Transactions

• The Board approved the award of an aggregate of 74,000 non-qualified stock options to members of the Board and management of the Company, contingent on stockholder approval of the Plan Amendment Proposal.

Stakeholder Impact

• **Shareholders**: Will vote on the proposed increase in the equity incentive plan shares, which could lead to future dilution. Their understanding of voting procedures and eligible votes has been clarified.
• **Management and Board**: Stand to receive significant stock option awards if the Plan Amendment is approved, which aims to align their incentives with the Company's performance and shareholder value.
• **Employees**: While no specific awards are detailed for non-executive employees in this supplement, the increased share pool for the 2020 Equity Incentive Plan could allow for future grants to them, potentially enhancing retention and motivation.

Next Steps

• Stockholders are urged to vote by proxy or attend the Special Meeting on August 6, 2025.
• The Company will hold the Special Meeting of Stockholders on August 6, 2025.
• If Proposal 2 is approved by stockholders, the Company anticipates making material additional grants under the 2020 Plan to members of its management team and Board shortly after the Special Meeting.

Key Dates

Recommendation

Keywords

SEC filing, proxy statement, stock options, equity incentive plan, corporate governance, shareholder meeting, executive compensation, board compensation, TAO Synergies Inc., Nasdaq